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Implementation science for ambulatory
care safety: a novel method to develop
context-sensitive interventions to reduce
quality gaps in monitoring high-risk
patients
Kathryn M. McDonald1,2*, George Su3, Sarah Lisker3, Emily S. Patterson4 and Urmimala Sarkar3
Abstract
Background: Missed evidence-based monitoring in high-risk conditions (e.g., cancer) leads to delayed diagnosis.
Current technological solutions fail to close this safety gap. In response, we aim to demonstrate a novel method
to identify common vulnerabilities across clinics and generate attributes for context-flexible population-level
monitoring solutions for widespread implementation to improve quality.
Methods: Based on interviews with staff in otolaryngology, pulmonary, urology, breast, and gastroenterology
clinics at a large urban publicly funded health system, we applied journey mapping to co-develop a visual
representation of how patients are monitored for high-risk conditions. Using a National Academies framework
and context-sensitivity theory, we identified common systems vulnerabilities and developed preliminary concepts for
improving the robustness for monitoring patients with high-risk conditions (“design seeds” for potential solutions).
Finally, we conducted a face validity and prioritization assessment of the design seeds with the original interviewees.
Results: We identified five high-risk situations for potentially consequential diagnostic delays arising from suboptimal
patient monitoring. All situations related to detection of cancer (head and neck, lung, prostate, breast, and colorectal).
With clinic participants we created 5 journey maps, each representing specialty clinic workflow directed at
evidence-based monitoring. System vulnerabilities common to the different clinics included challenges with:
data systems, communications handoffs, population-level tracking, and patient activities. Clinic staff ranked 13
design seeds (e.g., keep patient list up to date, use triggered notifications) addressing these vulnerabilities. Each
design seed has unique evaluation criteria for the usefulness of potential solutions developed from the seed.
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Conclusions: We identified and ranked 13 design seeds that characterize situations that clinicians described
‘wake them up at night’, and thus could reduce their anxiety, save time, and improve monitoring of high-risk
patients. We anticipate that the design seed approach promotes robust and context-sensitive solutions to safety
and quality problems because it provides a human-centered link between the experienced problem and various
solutions that can be tested for viability. The study also demonstrates a novel integration of industrial and
human factors methods (journey mapping, process tracing and design seeds) linked to implementation theory
for use in designing interventions that anticipate and reduce implementation challenges.
Keywords: Organizational interventions, Diagnostic error, Ambulatory care, Cancer, Patient safety, Human factors,
Journey mapping, Design seeds, Patient monitoring
Background
A seminal National Academy of Medicine (NAM) report
asserts that most people will experience at least one
diagnostic error – a delayed or inaccurate diagnosis – in
a lifetime, “sometimes with devastating consequences.”
[1]. In ambulatory care, one of 20 patients in the United
States experiences potentially preventable diagnostic er-
rors annually [2, 3]. Missed cancer diagnoses are the
leading reason for paid medical malpractice claims in
the ambulatory setting [4, 5].
Widespread research across specialties demonstrates
that inadequate monitoring in high-risk outpatients
leads to preventable high-risk events and significant pa-
tient harm [5, 6]. For example, patients who have a posi-
tive fecal blood test but no follow up colonoscopy within
a reasonable time period may experience a missed op-
portunity to detect and successfully treat colon cancer
[7, 8]. The National Comprehensive Cancer Network
has monitoring guidelines for screening (active and ini-
tial) as well as post-treatment cancer recurrence surveil-
lance [7, 9–17]. Proactive and efficient strategies to
respond to high-risk situations—such as overdue im-
aging or blood tests—are urgently needed to reduce
the safety gap in evidence-based monitoring for can-
cer [18–23].
Impoverished populations (those served by “safety-net”
settings in the United States) are particularly prone to
failures in patient monitoring, given high prevalence of
limited health literacy, as well as barriers like lack of
transportation, inability to leave work for medical appoint-
ments, and a myriad of other obstacles to engaging with
the health care system [24–27]. At the same time safety-
net health systems often lack critical Health Information
Technology (HIT) infrastructure and resources (e.g.,
personnel time) to devote to monitoring these vulnerable
populations [28]. Common software development prac-
tices favor mass production and rapid adoption over
user-specified customization necessary for long-term
sustainability for challenging workflows [29, 30]. To
accomplish robust patient monitoring and prevent
adverse events, it is critical to identify setting- and
population-specific vulnerabilities and needed at-
tributes of effective interventions, whether technical,
social, organizational or a combination.
Theories for complex delivery system interventions
stress the importance of studying human and contextual
aspects of change [31, 32]. The interactions between and
within multiple levels of the health care system are pos-
ited to affect quality improvement projects [33]. The
recent NAM Improving Diagnosis report included a
high-level conceptual framework with these factors,
among others such as clinical reasoning and teamwork
that contribute to diagnostic safety and improvement
[1]. The NAM framework explicates that patient and
systems outcomes are produced by the diagnostic
process which evolves over time, within the context of a
larger work system composed of diagnostic team mem-
bers, tasks, technologies and tools, organizational ele-
ments, and the physical environment [34–37]. To
reduce the chance of missing a cancer diagnosis, vulner-
abilities need to be addressed within both the ambula-
tory care’s diagnostic process and work system. In other
words, what work system factors produce robust moni-
toring (systems outcomes) and fewer diagnostic errors
(patient outcomes)? Research in this area is nascent,
with many unknowns about specific vulnerabilities,
patient safety intervention opportunities, and subsequent
implementations [1, 38]. Taylor et al identified four
theoretical domains of contextual features determined
by expert consensus as important for patient safety
intervention implementations: safety culture, teamwork
and leadership involvement; structural organizational
characteristics; external factors; and availability of imple-
mentation and management tools [39, 40].
To develop theory-based, context-informed organiza-
tional interventions for closing the safety gap, our study
introduces a unique integration of user experience and
human factors methodologies: journey mapping and design
seeds. We apply journey mapping to clinician-centered
workflow focused on patients at high risk for a missed
monitoring opportunity to diagnose cancer [41]. Previous
applications have taken the perspective of an individual
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patient’s journey within a health care setting [42–44]. De-
sign seeds are solution attributes that separate the goal of a
modular intervention (e.g., alerting patients that they need
to return to the clinic) from the means for achieving it
(e.g., use of a web portal messaging system) [45]. They have
the advantage of generating multiple solutions to the same
problem so unknown vulnerabilities and preferences can
be uncovered, interventions can be tailored to different
contexts, and more solution variations can be considered
to evaluate correct fit [46]. To apply design seeds to patient
monitoring,1 we draw from a somewhat analogous situ-
ation studied outside of health care: intelligence analysts
who experience time pressure and data overload as they
cull through numerous documents to identify national
security threats [47]. Our approach will inform prototy-
ping, piloting and full-scale testing of technical and
organizational interventions, with the aim of producing ro-
bust population-level monitoring solutions for widespread
implementation.
Methods
Design
We conducted formative research, following a 6-stage
co-development process between the research team and
frontline clinicians (attending doctors, residents, nurse
practitioners, registered nurses) to identify solution attri-
butes of a comprehensive intervention for more robust
monitoring of high-risk cancer conditions over time
(Table 1). The research team applied human factors
strategies and organizational theory about complex
adaptive systems within five specialty clinics to identify
vulnerabilities and generate desirable solution attributes
for interventions [1, 39, 48, 49].
Setting
The San Francisco Health Network is a publicly funded,
integrated health network operating under the auspices
of San Francisco’s Department of Public Health and in-
cludes 14 primary care clinics, urgent care, and specialty
care at Zuckerberg San Francisco General Hospital. Last
year, there were 539,310 outpatient visits at the hospital
alone [50].
The health system serves many of the most medically
and socially vulnerable patients in San Francisco. Pa-
tients seen at the network’s main clinic and hospital are
diverse: 17% are African American, 35% are Latino,
21% are White, and 21% are Asian. Services are pro-
vided in over 20 languages. Based on outpatient days,
only 1% of the population has commercial insurance,
10% uninsured, 57% Medi-Cal, 21% Medicare, and the
remaining 11% covered by other mostly public sources
[51]. Others have categorized hospitals according to
safety-net burden, with high-burden ranging from 33 or
36% to 100% of patients as those with Medicaid or no
coverage [52, 53].
Like many safety-net systems and ambulatory prac-
tices, the health system does not have a comprehensive
electronic health record system and struggles with infor-
mation transfer as well as fragmentation of health infor-
mation across over 50 electronic platforms. Despite
some of the HIT challenges and known workarounds
typical of these safety-net settings, the organization has
a longstanding commitment to both human-centered
strategies (patient-centered medical home, plan-do-
study-act cycles) and Lean management methods [54].
Table 1 Co-Development Research Process
Key Questions Based on NAM Improving Diagnosis Framework
PROBLEM: What vulnerabilities exist in monitoring outpatients for high
risk conditions (e.g., cancer)?
SOLUTION: What elements of work systems and the diagnostic
process are important to produce robust monitoring & thereby
reduce diagnostic errors?
Stage 1: Identify 5 High-risk Populations and Clinical Informants
• Review literature
• Corroborate with local clinicians taking care of these patients
• Determine with clinical leadership who to interview, based on
responsibility for patient monitoring (2-3 clinicians/clinic; 11 total)
Stage 2: Develop Journey Maps
• Identify key participants to learn about workflows for each high-risk
population
• Elicit with semi-structured interview a description of the patient and
data flow from worker’s vantage
• Visualize this information into swim lanes or “clusters” of activities
• Show swim lanes to participants and revise (as needed)
• Visit clinic sites to observe critical parts of process (as needed)
Stage 3: Generate Vulnerability List
• Abstract vulnerabilities from interview notes and journey maps
• Return to clinic participants to validate the list (one or more clinic has
indeed experienced vulnerability)
• Map validated list of items to theory domains from applicable patient
safety frameworks [1, 60]
Stage 4: Analyze Journey Maps for Commonalities
• Categorize types of activities in the journey using human factors
method of process tracing (novel extension to derive tracings from
journey maps)
• Generate process trace sequences for each clinic’s workflow [61]
• Look for patterns of workflow that are similar and variable across
the 5 populations
Stage 5: Develop Design Seeds for Interventions and Link to
Implementation Theory
• State what a solution would need to do to address vulnerabilities
identified from previous stage
• Reduce the list to solution attributes (design seeds) that address common
problems and needs across clinics
• Aim for design seeds that meet the generic needs of robust monitoring
and that enable evaluation
• Hypothesize which contexts are likely to affect the effectiveness
of the implementation of the interventions emanating from the
design seeds using Taylor et al’s contextual domains and features
(see Additional file 3) [39]
Stage 6: Seek Reactions from Clinics on Design Seeds
• Assess anticipated impact (improved monitoring of patients, reduced
time spent by clinic team) and relative priority of each design seed
(see Additional files 1 and 2 for script and data collection instrument
used in each clinic)
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Evidence-based Safety Gaps Targeted (Stage 1)
Based on literature about missed and delayed diagnoses,
including reports from medical malpractice, we selected
five high-risk cancer situations—incidentally-discovered
pulmonary nodules, and monitoring for breast, colorec-
tal, prostate, and ear, nose, and throat (ENT) cancers—
for which coordination and timely use of data are
important for patient safety surveillance but challenging
to implement, particularly in safety-net and other low
resource settings [4, 5, 55]. These challenging high-risk
situations require recurring and timely follow-up care to
prevent harm [7, 9–17, 56].
Our team (GS, SL, KM) conducted a series of theore-
tically informed semi-structured interviews with partici-
pants from each of five specialty clinics responsible for
these high-risk patients: pulmonary medicine, breast
cancer, gastroenterology, urology and otolaryngology. As
part of these interviews, we corroborated the specific
safety targets by asking frontline clinicians: “What keeps
you up at night?” and “What are your clinical hunches
about who might fall through the cracks?” Although
providers talked about the types of patients lost to
follow-up, none of the clinics were enabled with a stan-
dardized and efficient method for quantifying how many
patients were lost to follow-up, why patients were lost to
follow-up, or even which patients were lost to follow-up.
Many other health networks share similar struggles with
incomplete documentation and measuring the real-time
scope of patient safety problems [57].
Mapping and Analyzing Clinical Workflows (Stage 2
through 4)
The interviews in each of the five cancer clinical settings
followed a user-centered design approach called journey
mapping, a tool widely used across multiple industries
[41, 58, 59]. Journey mapping derives from user experi-
ence initiatives in industry that informed the framework
proposed in the recent NAM Improving Diagnosis re-
port [1, 35, 60]. The method articulates and documents
a process through a specific point of view (typically, a
customer). In the health care field, it has been applied to
elicit individual patient journeys through the clinical
workflow [43]. Our team-based variation of journey
mapping has a patient population management view.
We elicit specialty care management through the experi-
ences of the clinical team as they try to track the host of
patient data required to monitor their high-risk popula-
tion. To our knowledge, this technique has seldom been
applied to the ambulatory setting, and has not been tar-
geted to clinic workflow efficiency or patient safety inter-
vention development.
We directed these journey mapping sessions to: (1)
isolate the steps in the patient monitoring journey that
are the most critical, time-intensive, and risky relative to
the safety gap, (2) identify critical data elements needed
to effectively and safely monitor patients, and (3) gather
potential attributes of organizational and technical inter-
ventions to ameliorate workflow problems. To construct
the journey maps, investigators (GS, SL, KM) probed
clinical participants with questions such as: “What are
you working on?” to elicit actions taken; “Who is re-
sponsible for which task?” to learn about monitoring-
related activities; “Are there external stakeholders?” and
“How important are they?” to surface coordination chal-
lenges outside of the clinic. Based on what participants
articulated, we constructed a journey map for each clin-
ical pathway with their review and endorsement. The
maps focus on the transfer of patient data throughout
the patient’s monitoring experience, starting with the ini-
tial diagnostic assessment and ending with the ongoing
follow-up. Whenever participants verbalized elements of
the pathway that were particularly vulnerable to error or
poor monitoring, we marked the activity with a bull’s
eye target, also referred to by clinicians as a ‘pain point’.
From the journey mapping sessions, we listed all of the
vulnerabilities experienced by at least one clinic. To verify
the list and gauge how many of the clinics experienced
each of the vulnerabilities, we returned to the clinic with a
data collection instrument (Additional files 1 and 2). We
also mapped the vulnerabilities corroborated by at least
one clinic to domains from patient safety theoretical
frameworks [1, 60].
Using standard process tracing techniques from human
factors, we categorized and summarized the sequence of
activities described in journey maps [61]. The trace se-
quences are used to determine the similarity of activity
flow among clinics that monitor high-risk populations as
well as any differences between clinics to inform well-
designed interventions.
Developing Design Seeds and Linking to Implementation
Theory (Stages 5)
Design seeds and the human factors approaches from
which they stem have been used outside of health care
for development of complex socio-technical interven-
tions [47, 62]. They serve as bridges to technical and
organizational solution options that can be designed dif-
ferently depending upon context, but that use common
attributes. As such, they offer an appealing addition to
the implementation science toolkit. In simple terms this
approach replaces the typical technical approach (Fig. 1a)
with a theoretically based socio-technical system under-
standing (Fig. 1b). As shown in Fig. 1b, design seeds link
the vulnerabilities experienced to potential solutions in a
specific and evaluable way. This promotes the evaluation
of a “seed” to a solution, rather than a full-fledged solu-
tion itself as is practiced in software development cycles
often used in HIT [63]. By jumping directly from
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“problem” to “solution,” one opens the door to various
misdirected applications that do not appropriately medi-
ate the diverse instantiations of a problem. The evalu-
ation of design seeds prior to the development of a
solution creates an opportunity for more cost-effective
and user-customized solutions [47].
Since a design seed features a series of evaluable state-
ments, the approach enables intervention testing at the
right point in the pathway for a specific action (e.g., does
the intervention work according to the design seed cri-
teria? yes, no, or partially). In order to set up theory-
based implementation, we (KM, SL) independently used
these statements to hypothesize which contexts are likely
to affect the effectiveness of implementation of the inter-
ventions emanating from the design seeds. We used
Taylor et al’s four contextual domains and 13 specific
features that a technical expert panel judged as high pri-
ority for assessment (as opposed to simple description)
in the evaluation of a varied range of patient safety inter-
vention implementations (Additional file 3) [39].
Assessing Clinician Reactions to Design Seeds (Stage 6)
To gain insight about the importance of the design
seeds, we developed and tested a data collection script
a
b
Fig. 1 a Technical Intervention Development Cycle. b Socio-Technical Intervention Development Cycle: Design Seed Theory. The figures
show that the socio-technical design seed intervention development adds an intermediate step that translates expressed vulnerabilities
into multiple solution possibilities and evaluation markers. In contrast to a singular solution provided when linking a problem directly to
a proposed solution, design seeds tease apart the expressed vulnerability to offer a distinct set of evaluable solutions that can be tested
independently. Design seeds yield a menu of modular options for implementers considering differing organizational context
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and instrument (Additional files 1 and 2). We then
returned to the frontline clinician participants from each
clinic, who reviewed each design seed, assessed likeli-
hood of improved monitoring and likelihood of reducing
time spent monitoring, and ranked the set of seeds for
relative overall importance.
Results
From January 2015 to February 2016, we convened one
or more journey mapping sessions with clinicians and
staff at five specialty clinics to establish the workflow for
monitoring high-risk patients. As expected, all clinics
participate in teaching alongside patient care, have simi-
lar patient demographics with accompanying operational
challenges (e.g., translation services, transportation
needs), and use the same underlying electronic health
record system but work within a larger system of frag-
mented record-keeping systems (e.g. different specialty-
specific EHRs, electronic systems restricted to on-site
devices, paper-based systems). The mapping process
also revealed variability in organizational approaches to
monitoring high-risk patients, including the types of
personnel involved in various monitoring-related tasks
(e.g. resident versus nurse responsibility for tracking)
and the specific steps taken to monitor high-risk pa-
tients (e.g., use of notebook-based list of patients versus
lack of a structured tracking tool).
Journey Maps: How Specialty Clinics Monitor High-Risk
Patients
For each clinic, we constructed a journey map as shown
in Fig. 2a, the abnormal colonoscopy workflow, and
Fig. 2b, the ENT cancer workflow. These journey maps
follow the management of patients with concerning con-
ditions requiring cancer surveillance, diagnosis, monito-
ring and treatment, starting with referral to the
respective subspecialty clinic. Each journey map contains
swim lanes (visual columns) to group similar activities,
flow arrows to represent patient and information move-
ment, and targets to highlight areas of vulnerability for
monitoring as expressed by clinic personnel.
For example, an abnormal colonoscopy triggers entry
into the gastroenterology clinic workflow (Fig. 2a), which
is adjudicated by the attending doctor. The first swim
lane clusters the activities related to referrals. The next
two swim lanes separate two different levels of diagnos-
tic concern and coordination – one for benign lesions
which just require notifying the primary care doctor, and
the other for “sinister” lesions which precipitate a series
of actions within the specialty clinic, as well as coordin-
ation with others based on subsequent findings (e.g.,
pathology, primary care, oncology). The bull’s eye target
on the box – “if no-show, patient falls off the list” –
means that the clinic is aware of this vulnerability, but
does not have any further, regular steps to reduce the
risk of losing a patient to follow-up. The bottom of the
diagram illustrates that patient-related contacting hap-
pens throughout the workflow; the associated target
conveys the challenges in reaching patients outside of
clinic and assuring that they can make it to follow-up
encounters.
The ENT clinic (Fig. 2b) reported similar challenges
contacting patients monitored and treated for cancer, as
did all other clinics (Additional file 4). The activities per-
formed by the ENT clinic for cancer monitoring cluster
into four swim lanes—case identification and referral,
coordination, consultation, and care pathway. In this
clinic, the coordination activities do not follow from a
particular clinical scenario (the benign versus sinister le-
sion), but instead relate to a particular role, the chief
resident. As a result, this clinic identified four separate
vulnerabilities related to the busy chief resident’s respon-
sibility to keep patients on the “ENT Radar” without any
specific tools besides paper notecards, while also coord-
inating resources such as transportation for patients,
tumor board presentations, and communication of
follow-up requirements to primary care providers
(PCPs). The care pathway swim lanes sketch out a series
of diagnostic activities and pre-treatment preparation.
The last stage of this clinic’s care pathway is patient
surveillance after treatment. No specific responsibility
assignment exists for patients who require regular sur-
veillance to monitor for cancer recurrence, so the on-
going surveillance activity box is labeled with a bull’s eye
target, indicating another vulnerability.
The journey maps intentionally tell only part of the
story as they represent the journey told from a single
clinic’s perspective. For example, all of the subspecialty
clinics have interactions with PCPs, but only when an
individual clinic spoke about dependencies on the PCP
for the patients that they monitor did we include the
PCP in a journey map. For incidental lung nodules,
breast cancer oncology navigation service, and abnormal
colonoscopies, the specialty clinics rely on the PCP to
remind patients to follow-up at the necessary intervals
since they have minimal contact with these patients.
Challenges Experienced in the Clinics
Based on the interview notes and journey maps from all
five clinics we developed a comprehensive list of vulne-
rabilities described by at least one clinic (see Table 2).
We identified 45 distinct vulnerabilities, and mapped
these to domains from patient safety theoretical frame-
works: 36 relate to work system factors that are inherent
to environment, task, technology, organization and
people, while 9 vulnerabilities correspond to process fac-
tors that reflect interactions between people or with sys-
tems [1, 60]. Each clinic reviewed the list at least four
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months after journey mapping to validate high-priority
vulnerabilities that persist over time despite ongoing
organizational changes and to record differences bet-
ween clinics. Only two vulnerabilities—1) have to track
some patients in own mind or side system, and 2)
creating list of patient requiring monitoring takes time –
were experienced by all five clinics. At least two clinics
(in varying combinations) experienced most of the vul-
nerabilities. Four of the five clinics verified multiple
problems related to the time expended on tasks related
a
b
Fig. 2 a Abnormal Colonoscopy Journey Map. b Ear Nose and Throat (ENT) Cancer Journey Map. Investigators constructed journey maps that
follow the management of patients who are being monitored and treated for cancer, as articulated by clinical participants. Similar activities and
actions are clustered into vertical “swim lanes,” arrows indicate the flow between actions, and bull’s eye targets mark actions that are particularly
vulnerable to missed monitoring. For example, an action that does not have an “owner” may instigate a higher risk for patient loss to follow-up
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Table 2 Vulnerabilities Experienced by Each Clinic
Vulnerability from Specialty Clinician Perspective # of Clinics
Experiencing
Clinic (X = experienced)
Classified by Framework Domaina B P GI E U
Work System: Task
Have to track some patients in own mind or side system 5 X X X X X
Creating list of patients requiring monitoring takes time 5 X X X X X
Looking up each patient’s information takes time 4 X X X X
Maintaining list of patients requiring monitoring takes time 4 X X X X
Outside of visit-based care, don’t always know when patients need follow-up
monitoring
4 X X X X
Manually monitoring patients is time intensive 4 X X X X
Don’t always know which patients need to be called back for monitoring 3 X X X
Have to spend too much time scheduling 2 X X
Manually monitoring patients is error-prone 2 X X
Work System: Technology and Tools
Analyzing data in ad hoc manner is time intensive 4 X X X X
Inefficient system to create personal, siloed reminders for follow-up 4 X X X X
List of patients we use outdates quickly 3 X X X
Can’t divert alerts to other providers 3 X X X
Analyzing data in ad hoc manner is error-prone 3 X X X
Don’t always know when patient data is missing 2 X X
Can’t find missing data from outside clinic 1 X
Don’t always want alert when patient status changes 1 X
Don’t have adequate real-time data 1 X
Can’t edit patient’s care pathway as needed based on frontline data 1 X
Can’t find missing data within clinic 1 X
Work System: Organization
Systems don’t talk to each other 4 X X X X
Don’t have a system that puts patients into subgroups for more efficient
monitoring
4 X X X X
Can’t share patient list with entire care team 3 X X X
Don’t always have the time to perform the assigned role 2 X X
Hard to stratify patients into subgroups for monitoring due to many individual
patient differences
2 X X
Care plan is poorly documented 2 X X
Don’t know what types of scheduling challenges occur most often 1 X
Work System: People
Overlapping efforts 4 X X X X
Don’t always know when the loop closes 3 X X X
Everyone inputs data differently 2 X X
Knowing who is managing at each stage is unclear 2 X X
Mapping patient to care plan requires clinical judgment 2 X X
Work System: Environment
Coordinating scheduling efforts across care teams is difficult 3 X X X
Little or no performance data about monitoring so don’t know where to focus any
improvement efforts
3 X X X
Stretched for resources to reach out to all patients in need of follow-up 3 X X X
Unaware of clinic’s performance in patient monitoring 2 X X
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to monitoring. The breast cancer clinic experienced only
7% of the full list of possible vulnerabilities, while the
others experienced 12% to 34%. This lighter vulnerability
burden is perhaps because the breast clinic has separate
philanthropic funding that supports patient navigation
services, referred to by a participant as a “human trac-
king system”.
Several broad work system challenges emerged from
the clinic visits:
 Organized for visit-based care (as opposed to patient
management over time)
 Rotating care providers from visit-to-visit due to
being a teaching environment (as opposed to having
doctors with long-term organizational know-how)
 Lack of clear ownership for the monitoring-over-
time function (as opposed to task responsibility
and adequate time allocated for this population
management function)
 No aggregated real-time lists of those who require
follow-up monitoring (as opposed to supportive tools)
 Lack of systematic and transparent approach to
patient’s care plan (as opposed to widely known and
specified benchmarks and timing for monitoring
follow-ups)
 Substantial time pressure limits frontline attention
to learning from missed monitoring incidents (as
opposed to efforts to analyze data about misses,
understand vulnerabilities and develop organization-
wide solutions)
This work environment analysis that utilizes the NAM
framework underscores the lack of infrastructure and
processes organized to support population-level tracking
of patients undergoing diagnosis of initial cancer,
progressing cancer or recurring cancer. One noteworthy
finding was the lack of population-level descriptions of
the different types of monitoring care pathways com-
monly used within a given clinic. For example, the ur-
ology clinic participants – an attending doctor, a
resident and a nurse – described a composition book
where the resident logs all urologic patients who had a
pathology result. The composition book is a starting
point for population-level tracking of those who are at
some risk for being lost to follow-up despite likelihood
of needing it. However, the list is not sub-divided or ca-
tegorized based on findings, conditions, anticipated
follow-up pathway (e.g., testing, timing of next visit).
The clinic participants noted that they preferred a sys-
tem to monitor for all urologic cancers rather than
restricting to prostate cancer monitoring (journey map
focus) and that the composition book re-emerged as a
workaround after a technical monitoring system was
unsuccessful.
Process Trace Sequences: Four Critical Activities for
Monitoring High-Risk Patients
To simplify the journey maps and enable pattern recog-
nition across clinics (see Additional file 5 for color-
coded journey maps), we categorized each action into
one of three functional clusters:
 Communicate/coordinate
 Patient activity (contact patient, patient shows up)
 Review or enter data/data systems
Figure 3 shows the resultant process trace sequences
derived from the journey maps for each of the five
clinics. The workflows have similar patterns: review and
entering data at the beginning of the journey; a couple
Table 2 Vulnerabilities Experienced by Each Clinic (Continued)
Process: System-Patient Interaction
Don’t know when patient misses appointment 4 X X X X
Don’t always know when patient doesn’t have PCP 4 X X X X
Don’t always know patient’s vulnerabilities relevant to monitoring (e.g. patient’s work
schedule, can’t get to clinic, substance abuse)
3 X X X
Difficulty communicating patient needs with entire care team 2 X X
Don’t know when patient changes status 2 X X
Process: System-Provider Interaction
Inconsistent process for informing PCP 3 X X X
Can’t use patient data for operational improvement 2 X X
Involving PCP when not necessary 1 X
Process: Patient-Provider Interaction
PCP doesn’t have overview of all patient info/care pathway 3 X X X
aAdapted from the National Academy of Medicine Improving Diagnosis Framework, 2015 and Sarkar et al’s System-related Factors, 2014 to classify each reported
vulnerability into Work System versus Process, as well as subdomains of these two framework categories [1, 60]
Legend: Clinics designated as B = Breast, P = Pulmonary, G = GI, E = Ear Nose and Throat, U = Urology
McDonald et al. Implementation Science  (2017) 12:79 Page 9 of 17
activities to communicate and coordinate within the
clinic team before seeing a patient, a series of tests and
appointments where the patient has to show up, and
some patient contact outside the appointments punctu-
ating the middle of the journey; and more communica-
tion or coordination actions marking the end of the
journey. As noted in the thematic analysis, a fourth crit-
ical activity weaves through the sequence:
 Track progress related to patients and their follow-
up needs
Design Seeds: Elements of a Comprehensive and
Adaptable Intervention to Save Lives and Time
To inform intervention development, we looked for le-
verage points to alleviate the vulnerability areas that held
the highest consequence for failure. We generated a list
of 13 leverage points, called design seeds, which corres-
pond to the critical activities for robust patient monito-
ring, as shown in Table 3. One of the clinics, urology,
told us that they had a registry but it was not used. This
situation exemplifies the typical solutions pathway, as
shown in Fig. 4a. In contrast, based on socio-technical
theory, stating simply that a registry “is needed” is too
minimalistic and fails to take the organizational context
and its potential variations into account. Figure 4b pro-
vides an example of the design seed description for func-
tions needed in a population registry of high-risk patients
requiring monitoring. The design seed communicates the
intent behind the recommendation resulting in a modular
- therefore more evaluable - set of solution attributes.
Each of the four functions (e.g., groups patients by PCP)
shown can support different components of an interven-
tion. In addition, each design seed functional statement
can easily be converted into an evaluation question, such
as “does the intervention use data visualization in a way
that enables rapid identification of patients in need of
follow-up?” or “does the intervention allow our clinic to
prioritize work in a way that assures that the highest risk
patients receive follow-up first?” (Additional file 1 has the
detailed functional descriptions for each of the design
seeds, as presented to the clinics for feedback.) These de-
scriptions also support hypothesis-generation about con-
textual features that may have variable effects on whether
the intervention is able to achieve its intended design
goals(Table 3) (Additional file 3 shows our hypothesized
relationships between context features and design seeds).
When clinic participants were presented the prelimi-
nary findings from this formative research, they were
asked to prioritize the design seeds and suggest revisions
of the design seed descriptions. Twelve of the 13 design
seeds received ranking in the top 5 in at least one clinic
(Table 4). Although the design seed for scheduling func-
tionality did not receive a top 5 ranking, four clinics
ranked it seventh, right in the middle of the list, so it
was hardly a low priority. The design seed for keeping
the list of patients who need monitoring up-to-date re-
ceived top three or better ranking at four clinics. Three
other design seeds – triggered notifications, customize
the patient list, and population registry functionality –
were ranked in the top 5 by three or more clinics. As
noted by one participant, the high priority seeds or solu-
tion attributes “were those that bring the right informa-
tion to the right person at the right time.” Some design
seeds had higher salience for only one clinic. Complete
data capture, for example, is more problematic for
clinics whose patients receive some of their care at other
institutions that use other record-keeping systems and
EHRs. In these instances, patient data is either inacces-
sible or must be faxed between sites.
Fig. 3 Process Trace Sequences. The display shows process trace sequences of major activities, and the constant tracking to monitor high-risk
patients. Each clinic sequence is derived from a tricolor-coded version of its original journey map (Additional file 5).
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Based on average ratings shown in Table 4, as well as
individual clinic ratings, the design seeds received agree-
ment that they would improve monitoring and save time
in most clinics. Only one design seed (assigning roles)
received disagreement for improving monitoring and re-
ducing time in one clinic because all monitoring is per-
formed by a “one-woman show” (a registered nurse). All
design seeds except one (patient support) received the
most favorable rating (5) for time saved by at least one
clinic. No clinic provided very strong agreement (5) that
the design seed for performance data would improve
monitoring, although representatives of three clinics
(breast, GI and urology) agreed that it would improve
monitoring (ratings of 4 on 5-point scale). As one re-
spondent noted, “the scope of the problem would be
good to know, but secondary to other needs.” This view
is consistent with other studies showing frontline con-
cern that monitored activities will be artificially priori-
tized over core clinical work [64]. Design seeds viewed
as having higher impact potential for saving time and
improving monitoring were generally ranked closer to
the top by more clinics.
Discussion
This research highlights the unique and innovative inte-
grated application of methods drawn from human fac-
tors engineering (design seeds, process tracing analysis)
and user experience studies (journey mapping) to derive
context-sensitive and theory-based interventions at the
local level. Such focused and potentially scalable work is
particularly needed for patients who may be lost to
follow-up in systems that are stretched for dollars and
time. This project focused on high-risk patients, both
clinically due to a potentially concerning finding during
an outpatient visit, and due to challenges from a socio-
demographic viewpoint. When a patient has a warning
signal for a serious condition that has yet to materialize,
but may in the future, the ability of a clinical team to
watch the patient closely over time hinges on incredible
vigilance on the part of individual clinicians - hardly an
ideal solution.
These challenges mirror those reported in other health
settings with incomplete documentation and limited
knowledge of the magnitude of patient safety problems
[57]. Providers will often create informal workarounds in
response to the lack of comprehensive and coordinated
record-keeping systems, which can result in errors as
well as redundant efforts [65, 66]. Accompanied by an
understanding of these workarounds, resource strapped
settings offer a unique opportunity to apply user-centered
approaches to redesign socio-technical strategies by inte-
grating user and client needs, the possibilities of technol-
ogy, and requirements for economic viability [67].
Through mapping how patients are currently moni-
tored for specific high-risk conditions according to
evidence-based practice in five specialty clinics in our
safety-net setting, we identified 45 different vulnerabil-
ities. Repeatedly, we heard that clinicians worry about
properly tracking these patients, and are troubled by the
significant personnel time required in carrying out
Table 3 Design Seeds Relationship to Critical Activity Categories and Implementation Context
Critical activity
category
Design seed Relevant Context Domains [39]
Safety Culture,
Teamwork, Leadership
Structural Organizational
Characteristics
External
Factors
Implementation/
Management Tools
Communicate/
coordinate
Ability to control data access X X X X
Scheduling functionality X X X
Assign roles and responsibilities X X X
Triggered notifications X X X X
Patient activity Patient support X X X X
Complete patient information X X X
Review or enter
data
Keeps list up-to-date X X X
Standardized data entry X X
Complete data capture X X X
Performance data X X X X
Track progress Population registry functionality for
high-risk patients
X X
Figure out what patients are “on
the list”
X X X X
Customize the patient list X X X
Legend: Design seeds correspond to the four critical activities performed by clinics. To maximize effectiveness in diverse and dynamic settings, designed interventions
are considered within the context of a larger work system, split into four major domains by Taylor et al. Hypothesized relationships between context features
(e.g., leadership at unit level, local tailoring of intervention) within the four context domains and each design seed are shown in Additional file 3
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patient-level monitoring activities without tools and
organizational approaches for population-level monito-
ring. In addition, no ongoing performance data currently
exists related to the frequency of missed opportunities
to monitor these high-risk patients, though efforts are
underway [27].
To ameliorate the difficulties identified, we worked it-
eratively with the clinics to develop the basis for a sound
approach to population management of diagnostically
high-risk patients. We adapted the journey mapping
technique to capture activities and experiences of the
clinic team as they manage cohorts of such patients,
focusing on the clinician’s monitoring journey. Pre-
vious applications have focused on patient journeys
and experiences. While each clinic had a different
journey map, all teams carried out the same four
basic functions with some variation in sequencing and
specifics. For example, one function, ‘patient activities’,
includes scheduling the patient, assisting patients with
barriers to making it to a critical test, seeing the pa-
tient when they come into the clinic, conducting an
imaging study, and so forth.
a
b
Fig. 4 a Technical Intervention Development Cycle: Example. b Socio-Technical Intervention Development Cycle: Design Seed Example.
The Pivotal Role of Design Seeds for Intervention Development: Design seeds offer an important bridge between identifying problems
and solutions. For the design seed– a population registry for high-risk patients – the diagram shows the evaluable components of the
design seed in the light blue boxes. At the solution development stage, different technical and/or organizational interventions can be
tested to see if they meet the design seed requirement. Solution components, shown in dark blue boxes, that meet the design seed
requirement (based on iterative testing) can be assembled as a comprehensive intervention for further testing and deployment
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Once we understood the clinic teams’ many concerns,
particularly the time implications of the current moni-
toring workload, as well as the potential for errors, we
did not jump straight to solutions. The use of design
seeds, as a bridge between problems and effective
organizational interventions, offers three advantages to
leaping over this step. First, design seeds are simple de-
scriptions that state what a solution needs to do, and
can be described in a way that allows validation by the
users, those on the frontlines at the clinics. For example,
clinicians can easily imagine scenarios where patients
might not be monitored according to evidence-based
guidelines because of ambiguity in who is responsible
for tracking high-risk situations (i.e., addressed by the
design seed for assigning roles and responsibilities be-
tween primary care practitioner and specialist for a pa-
tient flagged for further follow-up). Second, design seeds
can be supplied to other clinics to learn whether they
have face validity outside of this particular safety-net set-
ting. Design seeds support flexibility and tailoring to
context, a critical feature for effective implementation of
patient safety interventions in different settings [39, 68].
Other clinics could use the feedback exercise to determine
whether the 13 design seeds are perceived to improve
monitoring and save time in their setting prior to invest-
ing in a solution. As a result, one organization could im-
plement and test interventions based on one set of design
seeds (e.g., #3, 5, and 7), while another might choose
another set (e.g., #2, 3, 4, 6) based on differing contextual
enablers, barriers and interactions [33, 37, 39, 40]. Third,
design seeds are, by definition, an assessment tool during
testing of potential solutions. Does the solution do what
the design seed prescribed? Some of the design seeds may
result in primarily HIT solutions (triggered notifications),
while others may need significant organizational changes
(patient support). But most, if not all, will likely require
both technical and organizational change.
The use of design seeds, previously applied for com-
plex cognitively rich tasks outside of health care, is
adaptive to any organizational setting coordinating
layers of cognitively taxing activities meant to accom-
plish a particular organizational goal [69, 70]. Health
networks fragmented by technology, location, and
organizational elements are ripe environments for the
design seed method as it captures differences in context
while moving towards a cohesive end-goal: a solution
that works across settings while also targeting specific
needs to provide high value to local settings. In our
case, we sought to use journey mapping coupled with
process tracing and design seeds to identify features of
population management interventions for high-risk
conditions and treatments to reduce diagnostic error.
The flexible structure of these tools, anchored to touch
points with end users, enable a generalizable strategy
for identifying leverage points, reducing diagnostic de-
lays related to suboptimal monitoring, and increasing
organizational effectiveness.
Limitations
While designed for adaptability across systems, our pro-
posed strategy for developing design seeds would be
strengthened by further assessment within other health
care systems. At this stage, we know from testing in mul-
tiple specialty settings that common themes and variations
exist. While each of the clinics in this study has its own
leadership, electronic and paper-based systems, and
organizational design, we showed that journey mapping
Table 4 Importance Ranking of Design Seeds from Five Specialty Clinics
Design Seed Ranked in Top 5 Rank
(Avg)
Improved Monitoring
(Avg)
Reduce Time Spent
(Avg)
Keeps list up-to-date P, G, E, U 3.4 4.6 4.8
Triggered notifications B, G, E 4.2 4.8 4.8
Customize the patient list B, P, G, U 5.2 4.2 4.6
Ability to control data access E, U 6.2 4.4 4.2
Population registry functionality for high-risk patients P, E, U 6.6 4.4 4.2
Complete patient information G, E 7.2 4.6 4.6
Standardized data entry G 7.2 4.2 4.4
Performance data B 7.2 3.6 3.8
Patient support B, P 7.8 4.2 3.6
Complete data capture B 8 3.8 4.2
Scheduling functionality - 8.4 4 4
Figure out what patients are “on the list” P 9.8 4.2 4.2
Assign roles and responsibilities U 9.8 3.4 3.6
Legend: Clinics designated as B = Breast, P = Pulmonary, G = GI, E = Ear Nose and Throat, U = Urology
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paired with process tracing captured both differences and
similarities across five settings.
Because data collection was part of quality improve-
ment work in a low resource setting, we relied on a
small number of informants from each clinic. An addi-
tional limitation is that our design seeds have not re-
ceived feedback from stakeholders outside the specialty
clinic workforce (e.g. patients, information technology
providers, caregivers). Any vulnerability tied to patient
knowledge or preferences would best be elicited from
patients directly, and most likely generate refinement of
the patient support design seed. By focusing on the
“holders” of the patient data – those stakeholders that
most frequently engage with, and bear responsibility for,
patient monitoring activities – we have established a
foundation from which to build. The approach used fos-
ters an iterative process for data collection that will loop
in other stakeholders. Our adaptation of journey map-
ping and design seeds summarizes a broad, but possibly
incomplete, list of activities related to patient monitoring
when approached from a cohort perspective.
Future Work
We sought to draw from organizational analysis used
outside of the healthcare setting to inform a practical
and scalable intervention geared to reduce missed and
delayed diagnosis in high-risk patient populations.
Ideally, this approach would be replicated in other spe-
cialty areas and sites, including those that are better
resourced. We will translate the validated design seeds
into a prioritized list of solution attributes to use in de-
velopment and evaluation of socio-technical interven-
tions. During the organizational change process, we
intend to continually reference and iterate journey maps.
One of the design seeds – figure out what patients are
“on the list” – will require work within the clinics as well
as literature reviews targeted to trigger algorithms for
identifying patients in need of close, but not urgent,
follow-up during their diagnostic journeys [71–73]. We
anticipate that interventions evaluated against user
needs that are generated with intention and context will
be more sustainable, user-friendly, and implemented
more successfully than those generated without this
human factors approach.
As a nascent area of research, strategies to close gaps
in diagnostic safety built from the ground up, as in this
study, will first be followed by pilot testing, and ulti-
mately full-scale implementation evaluations with addi-
tional measures related to the people (patient, provider),
organizational, technology and structural factors predic-
ting desired implementation outcomes [74]. The NAM
Improving Diagnosis framework shares a similar multi-
level structure with those of implementation science,
anticipating future research to improving diagnostic care
in an organizationally effective and sustainable way.
Conclusions
We carried out a multi-stage research process with spe-
cialty clinics at an urban publicly funded health system
to address an important evidence-based safety gap in
ambulatory care: potentially preventable and consequen-
tial diagnostic and monitoring delays. Based on surfacing
a large number of common vulnerabilities among the
clinics, we specified and validated key attributes for a ro-
bust socio-technical approach to improving outpatient
monitoring that is geared to enable context-sensitive im-
plementation, utilizing industrial and human factors
methods linked to implementation theory.
Endnotes
1Patient monitoring for cancer, in this paper, is broadly
construed to include an expansive set of diagnostic oppor-
tunities, not just one definitive and staged cancer diag-
nosis. Ambulatory safety risk in this context includes
identification of high-risk patients, pre-diagnosis testing,
definitive diagnostic procedures (e.g., biopsies), and even
longitudinal post-diagnosis follow up (e.g., keeping track
of patients for whom treatment is delayed on purpose, or
following patients after treatment for cancer recurrence).
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